Effect of muscarinic agonists on the release of 3H-norepinephrine and 3H-dopamine by potassium and electrical stimulation from rat brain slices.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D002118:Calcium / Q000494:pharmacology; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004558:Electric Stimulation; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007444:Inulin / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D013779:Tetrodotoxin / Q000494:pharmacology; D014316:Tritium; D014508:Urea / Q000378:metabolism
D006584:Hexamethonium Compounds; D010277:Parasympathomimetics; D010643:Phenoxybenzamine; D014316:Tritium; D013779:Tetrodotoxin; D014508:Urea; D007444:Inulin; D000109:Acetylcholine; D011188:Potassium; D002118:Calcium; D004298:Dopamine; D009638:Norepinephrine